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Abstract
Matrix metalloproteinase-9 (MMP-9) cleaves collagen, allowing leukocytes to traffic towards the
vasculature and the lymphatics. When MMP-9 is unregulated by tissue inhibitor of metalloproteinase
1 (TIMP-1), this can lead to tissue destruction. Dendritic cells (DCs) infiltrate the oral mucosa
increasingly in chronic periodontitis (CP), characterized by infection with several pathogens
including Porphyromonas gingivalis. In this study, human monocyte-derived DCs (MoDCs) were
pulsed with different doses of LPS of P.gingivalis 381 and of E. coli type strain 25922, as well as
whole live isogenic fimbriae deficient mutant strains of P.gingivalis 381. Levels of induction of
MMP-9 and TIMP-1, as well as IL-10, which reportedly inhibits MMP-9 induction, were measured
by several approaches. Our results reveal that LPS of P.gingivalis, compared to LPS from E.coli type
strain 25922, is a relatively potent inducer of MMP-9, but a weak inducer of TIMP-1, contributing
to a high MMP-9/TIMP-1 ratio. Whole live P. gingivalis strain 381, major fimbriae mutant DPG-3
and double mutant MFB were potent inducers of MMP-9, but minor fimbriae mutant MFI was not.
MMP-9 induction was inversely proportional to IL-10 induction. These results suggest that LPS and
the minor and major fimbriae of P. gingivalis may play distinct roles in induction by DCs of MMP-9,
a potent mediator of local tissue destruction and leukocyte trafficking
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INTRODUCTION
Matrix metalloproteinase-9 (MMP-9) is a member of a family of proteolytic enzymes that
regulate cell-matrix composition by requiring zinc for their proteolytic activities. MMP-9
cleaves denatured collagen (gelatin), in particular, type IV collagen, which constitutes the
major component of the basement membranes (Opdenakker, et al., 2001, Matache, et al.,
2003, Ram, et al., 2006). This cleavage helps lymphocytes and other leukocytes like dendritic
cells (DCs) to enter and leave the blood and lymph circulations. MMP-9 also cleaves myelin
compounds such as myelin basic protein (MBP) and type 2 gelatins, which leads to remnant
epitopes that can generate autoimmunity (Opdenakker, et al., 2001, Matache, et al., 2003,
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Ram, et al., 2006). Expression and secretion of MMP-9 by activated lymphocytes and
monocytes is tightly regulated by cytokines, chemokines, eicosanoids and peptidoglycans
(Matache, et al., 2003). In most cell types, gene transcription of MMP-9 is inducible by
cytokines and cellular interactions. MMP-9 is secreted as a zymogen (proenzyme), which
remains inactive unless it is activated by the removal of the propeptide domain by proteolytic
enzymes like stromelysin-1, MMP-2 and other MMPs. MMP-9 is usually secreted together
with variable amounts of its specific inhibitor, tissue inhibitor of metalloproteinase 1 (TIMP-1)
which controls its proteolytic activity. Disturbances in the balance between MMPs and TIMPs
may result in excessive degradation of tissue, a condition often associated with chronic
inflammatory diseases like chronic periodontitis (CP), atherosclerosis, systemic lupus
erythematosus, Sjogren’s syndrome, systemic sclerosis, rheumatoid arthritis, multiple sclerosis
and polymyositis (Reynolds, 1996, Ejeil, et al., 2003, Ram, et al., 2006).
It is now recognized that in CP, MMPs play an important role in the degradation of collagen,
the major component of the extracellular matrix of the gingival tissue (Ingman T, 1994). CP
is initiated by a biofilm of bacteria on the teeth and below the gum-line, which often contains
Porphyromonas gingivalis, a pathogenic organism associated with CP (Colombo, et al.,
2009). The virulence factors of P. gingivalis, e.g. LPS, play a role in triggering inflammatory
responses in host tissues and can lead to bone loss (Nishida E, 2001). During CP, pathologically
elevated levels of active MMP-9 have been found in the saliva, gingival crevicular fluid, and
gingival tissue (Teng, et al., 1992, Makela, et al., 1994, Ingman, et al., 1996, Ejeil, et al.,
2003, Sorsa, et al., 2004). In addition, active forms of MMP-9 have been associated with
irreversible tissue destruction and the progression of periodontitis (Sorsa, et al., 2004). Several
studies have documented that P. gingivalis can also induce epithelial cells and
polymorphonuclear leukocytes (PMN) to secrete bioactive MMP-9. Human whole blood
stimulated with P.gingivalis LPS releases IL-1β, IL-8, MMP-8 and MMP-9 (Cazalis, et al.,
2009). The fimbriae of P. gingivalis are also important virulence factors, particularly in
invasion of epithelial cells (Yilmaz, 2002), dendritic cells (Zeituni, 2009) and in induction of
bone loss (Umemoto & Hamada, 2003). However, there is no information on the induction and
activation of MMP-9 by P. gingivalis in dendritic cells (DCs). DCs are the most potent antigen-
presenting cells (APC), possessing unique capacity to recognize and acquire microbial
antigens. Antigen acquisition can lead to DC maturation and expression of chemokine receptor
CCR7. Mature DCs disengage from the extracellular matrix, cross basement membranes, and
travel to draining lymph nodes to activate T cells (Dieu, et al., 1998, Yanagihara, et al.,
1998). We have previously shown that human gingiva contains at least two sub-populations
of DCs: Langerhans cells that populate the epidermis and dermal dendritic cells in the
connective tissues or lamina propria (Jotwani & Cutler, 2003). We and others have reported
that the number of DCs varies in human gingiva during health and disease, suggestive of active
trafficking of these cells (Jotwani, et al., 2004). Recent studies in mice have highlighted the
role of MMP-9 in DC migration in vitro and in vivo and have shown that DCs matured within
inflammatory sites require both CCR7 and PGE2-induced MMP-9 for their directional
migration to draining lymph nodes (Yen, et al., 2008). It has been shown that secreted MMP-9
can associate itself to CD44 and CD11b expressed by murine and human DCs (Ratzinger, et
al., 2002) which would allow activated DCs to use MMP-9 activity in a targeted manner for
directional migration to lymph nodes.
In the present study we hypothesized that DCs would be a significant source of MMP-9 and
TIMP-1 when challenged with the LPS of P. gingivalis or the whole live P. gingivalis;
furthermore, that fimbrial expression on P. gingivalis would alter MMP-9 induction. We
therefore analyzed MMP-9 and TIMP-1 levels from in vitro cultured monocyte-derived DCs
(MoDCs), when pulsed with LPS of P.gingivalis or whole live P. gingivalis strain 381 and its
isogenic fimbriae deficient mutant strains. We show that P. gingivalis LPS induces in DCs
elevated levels of bioactive MMP-9, but low TIMP-1 levels when compared to LPS from
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Escherichia coli type strain 25922. Interestingly, all strains with the exception of minor
fimbriae deficient mutant P. gingivalis strain MFI induced relatively high levels of MMP-9.
Overall, MMP-9 induction was inversely proportional to IL-10 induction by the different
strains. We surmise that a high MMP-9/TIMP-1 ratio induced by the periodontal pathogen P
gingivalis in part due to induction of low levels of IL-10 may contribute to DC responses in
CP.
MATERIALS AND METHODS
DC culture and isolation
MoDCs were generated by the procedure of Palucka et al. (Palucka, et al., 1998), as we have
previously described (Jotwani, et al., 2001). Briefly, monocytes were isolated from
mononuclear fractions of peripheral blood of healthy donors and seeded in the presence of
granulocyte-monocyte colony stimulating factor (GM-CSF) and IL-4 (1–2 × 105 cells/ml) for
6–8 days, after which flow cytometry was performed to confirm the immature DC phenotype
(CD14−CD83−CD1a+). Cell surface markers of DCs were evaluated by four-color
immunofluorescence staining with the following mAbs, at concentrations according to the
manufacturers’ recommendations (from 1–3 μg/ml, depending on the fluorochrome): CD1a-
FITC (BioSource International, Camarillo, CA); CD80-PE (BD Biosciences, Mountain View,
CA); CD83-PE (Immunotech); CD86-PE (BD PharMingen, San Diego, CA); HLA-DR-PerCP
(BD Biosciences); and CD14 APC (Caltag Laboratories, Burlingame, CA). After30 min at 4°
C and washing with staining buffer (phosphate-bufferedsaline [pH 7.2], 2 mM EDTA, 2% fetal
bovine serum), cells were fixed in 1% paraformaldehyde. Analysis was performed with
FACSCalibur (BD Biosciences). Marker expression was analyzed as the percentage of positive
cells in the relevant population defined by forward scatter and side scatter characteristics.
Expression levels were evaluated by assessing mean fluorescence intensity indices calculated
by relating mean fluorescence intensity noted with the relevant mAb to that with the isotype
control mAb for samples labeled in parallel and acquired by using the same setting.
LPS isolation
The methodology for isolation and purification of LPS from P. gingivalis 381 and E. coli
American Type Culture Collection (ATCC, Manassas, VA) type strain 25922 was as described
previously in our laboratory (Cutler, et al., 1996). Briefly, whole cell pellets were subjected to
hot-phenol water extraction; the aqueous phase was subjected to extensive dialysis against
distilled water, followed by lyophilization and then isopycnic density gradient centrifugation.
The LPS-containing fractions were dialyzed extensively against distilled water, lyophilized,
and subjected to biochemical analysis for purity. LPS was analyzed for protein content by the
bicinchoninic-acid protein assay (Pierce, Rockford, IL, USA). LPS samples were also
separated by SDS-PAGE and stained for protein with Coomassie blue and were uniformly
negative. Selected samples were also subjected to proteinase K digestion and nuclease
treatment, and reanalyzed by SDS-PAGE to confirm the purity of the LPS moieties (data not
shown).
Western blot analysis of MMP-9 secretion
MoDCs (5 × 105 cells/ml) were stimulated with indicated doses of P. gingivalis LPS and E.
coli LPS for 24 hours. The total protein concentration in each culture supernatant was
quantitated using protein assay kit (Bio-Rad Laboratories, Hercules, CA). Culture supernatants
were then analyzed for MMP-9 secretion. Aliquots of cell culture supernatants containing equal
concentrations of total protein [includes FCS in the medium] were suspended in equal volumes
of Laemmle sample buffer (Bio-Rad) and subjected to SDS-PAGE (8% gel) at 120V,
transferred to PVDF membrane at 25 V overnight and blocked with 5% blocking agent (ECL
blocking agent, Amersham Biosciences, Pittsburgh, PA) in PBS and 0.1% Tween 20. Primary
Jotwani et al. Page 3
FEMS Immunol Med Microbiol. Author manuscript; available in PMC 2010 July 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
anti-human MMP-9 [mouse anti-human immunoglobulin IgG1, clone GE-213, from Research
Diagnostics, Inc, NJ, USA] or was used at 1:15000, followed by incubation with horseradish
peroxidase-conjugated sheep anti-mouse IgG (Amersham Biosciences) at 1:50000 dilutions.
The proteins were detected using an enhanced chemiluminescence detection system
(Amersham Biosciences).
Zymography
MoDC supernatants were mixed with Tris-Glycine SDS sample buffer (2x) (Millipore) and
allow to stand for 10 min at room temperature. Samples normalized by volume according to
protein concentration were loaded on a 10% zymogram (gelatin) Gel. Samples were run with
1x Tris-Glycine SDS running buffer at 125V for approximately 90 min, or when the
Bromophenol blue tracking dye reached the bottom of the gel. After electrophoresis, gel was
removed and incubated in 1X Zymogram Renaturing Buffer (Triton × –100, 2.5% (v/v) in
water) (Millipore) for 30 minutes at room temperature with gentle agitation. After decanting
the Zymogram Renaturing Buffer, 1X Zymogram Developing Buffer (50mM Tris base, 0.2M
Nacl, 5mM CaCl2, 0.02% Brij 35) (Millipore) was added. Gel was equilibrated for 30 minutes
at room temperature with gentle agitation, buffer was decanted and fresh 1X zymogram
developing buffer was added. Gel was incubated at 37°C for at least 4 hours or overnight for
maximum sensitivity. The optimal result was determined empirically by varying the sample
load or incubation time. Gels were stained with Coomassie Blue R-250 for 30 minutes, then
destained with an appropriate Coomassie R-250 destaining solution (Methanol: Acetic acid:
Water (50: 10: 40). Areas of protease activity appeared as clear bands against a dark blue
background, where the protease has digested the substrate.
ELISA assay for MMP-9, TIMP-1 and IL-10
Supernatants of MoDCs pulsed with 100 ng P. gingivalis, E. coli LPS or P. gingivalis strains
at a 1:25 MOI for 24 hrs were analyzed in triplicate for MMP-1, TIMP-1 and IL-10 levels in
pg/ml, by quantitative sandwich enzyme immunoassay technique (ELISA), as described by
the manufacturer (Quantikine®, R&D systems, Minneapolis, MN).
Statistical analysis
All assays were performed in triplicate and results expressed as mean ± S.D., unless otherwise
indicated in figure legends. Data with parametric distribution were analyzed by Student’s t-
test, while non-parametric data were analyzed by Kruskal–Wallis test (Minitab®.ver. 15, State
College PA). Statistical significance was assessed at p<0.05.
RESULTS
P.gingivalis LPS is a highly potent MMP-9 agonist
We analyzed the ability of P. gingivalis LPS, at physiologically relevant doses of 10 ng and
100 ng (Copeland, et al., 2005) and a higher dose of 1000 ng, to induce secretion of MMP-9
by MoDCs, as determined by semi-quantitative Western blotting analysis (Fig. 1). P.
gingivalis LPS at 10, 100 and 1000 ng induced a dose-dependent increase in MMP-9 in relative
densitometry units (DU). The MMP-9 levels secreted by MoDCs in response to 100 ng and
1000 ng of P. gingivalis LPS was greater than that induced by equivalent dose of E.coli LPS
(Fig 1A, Fig. 1B).
Enzymatically active of MMP-9 is secreted by DCs in response to P. gingivalis LPS
To determine the gelatinolytic activity of the MMP-9 secreted by MoDCs, we performed
gelatin zymography (Fig. 2), and titered the LPS doses from 100 ng to 800 ng. We show that
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P. gingivalis LPS indeed induces higher levels of enzymatically active MMP-9 than E.coli
LPS (Fig. 2A, B).
High MMP-9/TIMP-1 ratio induced by P. gingivalis LPS as compared to E coli LPS
MMP-9 levels in cell supernatants were quantitated by ELISA (Quantikine ®, R&D systems,
Minneapolis, MN). The results in pg/ml (Fig. 2C) confirm Western blotting analysis and
zymography. P.gingivalis LPS induces significantly higher levels of MMP-9 (17.1 ± 0.02 ng/
ml) than E. coli LPS (4.8 ± 0.03 ng/ml) (Students t-test, p<0.05). We then determined the levels
of tissue inhibitor of metalloproteinase -1 (TIMP-1) in the MoDC supernatants. We show that
induction of TIMP-1 by P.gingivalis LPS was equivalent to E.coli LPS (Fig. 2D). Thus the
ratio of MMP-9/TIMP-1 induced by P. gingivalis LPS (= 3.25) was nearly three-fold greater
than that induced by E. coli LPS (=1.2).
Whole live P. gingivalis strains also induce MMP-9 production
Due to distinct roles for minor and major fimbriae in binding to and invasion of MoDCs
(Zeituni, 2009), we analyzed the ability of P. gingivalis strains to induce MMP-9 and TIMP-1
production. MoDCs were pulsed with type Pg 381 and its isogenic major- (DPG-3), minor-
(MFI) and double- (MFB) fimbriae deficient mutant strains {Takahashi, et al. 2006). We
observed that, with the exception of minor fimbriae mutant MFI, all the strains of P.
gingivalis induced high levels of MMP-9, ranging from 5.8–6.3 ng/ml (Fig 3A). This was
reflected in elevated MMP-9/TIMP-1 ratios with these strains (Fig. 3B). Minor fimbriae
deficient strain MFI, which expresses major fimbriae, induced ~6-fold lower MMP-9 levels
and 10–15 fold lower MMP-9/TIMP-1 ratio than the other strains (Fig. 3B). This correlates
with higher levels of IL-10 induced by MFI (Fig. 3C).
DISCUSSION
The pathogenic potential of P. gingivalis, the predominant pathogen associated with CP, has
been attributed to several virulence factors, including its fimbriae, a unique LPS and cysteine
proteinases {Lamont, 1998 #75}. Several lines of evidence suggest that in order to survive in
the hostile host environment, P. gingivalis must evade or subvert the host immune system
(Domon, et al., 2008, Hajishengallis, et al., 2008) by targeting innate immunity via these
virulence factors. P. gingivalis has also been called a ‘keystone” species due to its ability to
influence the entire oral microbial community by modulation of innate responses (Darveau,
2009). In the present study we show a role for P. gingivalis LPS in modulation of MMP-9 and
TIMP-1 by DCs. Our results show that P. gingivalis LPS is more potent in inducing bioactive
MMP-9 than E.coli LPS (Figs 1–3). Moreover while both LPS moieties increase TIMP-1 levels
compared to untreated control, the ratio of MMP9/TIMP1 is higher when MoDCs are
stimulated with P. gingivalis LPS. TIMP-1 functions as an inhibitor of MMPs by forming non-
covalent complexes with MMPs, thus blocking access of substrates to the MMP catalytic site
(Gomez, et al., 1997, Bode, et al., 1999). A high MMP/TIMP-1 ratio, therefore, implies an
imbalance or loss of MMP-9 regulation, as reported in inflammatory diseases such as lupus
nephritis (Jiang Z, 2009), encephalitis (Ichiyama T, 2009), appendicitis (Solberg A, 2008) and
periodontitis (Kubota T, 2008). While the present study was carried out in vitro, we used the
potent antigen presenting cells DCs, which infiltrate lamina propria in CP (Jotwani, et al.,
2001) and have been shown to contact P. gingivalis in situ.(Cutler, et al., 1999)
The reported structure of P. gingivalis LPS, particularly its diverse lipid A species, is associated
with its unorthodox targeting of TLR2, compared to TLR4 by E. coli LPS, used as a control
here (Fig. 1, 2). P. gingivalis LPS can also weakly stimulate TLR4, but potently antagonize
TLR4 activation by other stronger agonists (Darveau, et al., 2004). Our previous published
studies on the immuno-biological functions of P. gingivalis LPS with MoDCs have
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demonstrated that its LPS is also a weak inducer of MoDC maturation and induces a Th2
effector response, versus a Th1 effector response by E.coli LPS (Jotwani, et al., 2001,Jotwani
& Cutler, 2003). Differential TLR targeting, as well as our recent in press studies may offer
clues as to the mechanisms involved in the functional differences in P. gingivalis LPS,
including the MMP-9 observations here. We recently reported that P. gingivalis LPS induces
in DCs increased translocation of NFκB p50 subunits and of p50 homodimer formation into
the nucleus. Moreover, this same pattern of increased p50 subunits and of p50 homodimer
formation is found in tissues from CP patients (Jotwani, 2009). Induction of MMP-9 and
TIMP-1 has been reported to be transcriptionally regulated via the MEK/ERK pathway
(Maddahi, et al., 2009). The MEK-ERK pathway acts upstream of NFκB p50 homodimer
activity (Kurland, et al., 2003). Our results therefore imply a mechanistic link between the
unusual immuno-biological activities of P. gingivalis LPS as reported here, with the
intracellular signaling pathways and transcription factors that it induces.
Pulsing MoDCs with whole live P. gingivalis 381, as well as its major fimbriae deficient mutant
DPG-3 and double-fimbriae mutant MFB resulted in equivalent MMP-9 levels. This was not
the case however, with strain MFI, which has no minor fimbriae, but only expresses major
fimbriae (Takahashi, et al., 2006, Zeituni, 2009) and produces lower levels of MMP-9 (Fig.
3). This is interesting in that strain MFI induces in MoDCs much higher levels of inflammatory
cytokines, costimulatory molecules (Zeituni, 2009) and IL-10 (Fig 3C) than the other strains.
Low MMP-9 induction by major fimbriae seems to be due to the important role that IL-10
plays in inhibition of MMP-9 production (Lacraz, et al., 1995). The major fimbriae is reported
to target TLR2 (Davey, 2008)), as does P. gingvalis LPS, but this is apparently insufficient to
overcome the inhibitory activity of IL-10. TLR2 appears to be particularly important in IL-10-
mediated mucosal immune homeostasis in response to intestinal commensals (Cario, 2008).
In conclusion, in the present study we demonstrate by several techniques that P. gingivalis LPS
is a more potent inducer of MMP-9 in DCs than E. coli LPS. Combined with induction of
equivalent levels of TIMP-1 by both LPS moieties, this suggests a MMP-9/TIMP-1 imbalance
by P. gingivalis LPS that could contribute to chronic inflammation (Kubota T, 2008, Solberg
A, 2008, Jiang Z, 2009, Ichiyama T, 2009).. Elevated MMP-9/TIMP-1 was also induced by
the whole bacterium, except the minor fimbriae deficient mutant MFI, due to high levels of
MMP-inhibitory IL-10.
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Fig. 1. Semi-quantitative analysis of MMP-9 production by MoDCs in response to P. gingivalis LPS
and E. coli LPS
(A) Western blotting analysis of supernatants from MoDCs stimulated with 10, 100 and 1000
ng/ml of P. gingivalis (Pg) LPS and E.coli LPS or no LPS (control [ctl]) for 24 hrs. Equal
amounts of protein were loaded onto SDS-PAGE and separated by electrophoresis and
transferred to nitrocellulose membranes as described in the Materials and Methods.
Representative bands corresponding to 92 kDa (MMP-9). (B) Western blot bands
corresponding to 92 kDa (MMP-9) were quantified by optical densitometry (GelPro Analyzer,
Media Cybernetics, Silver Spring, MD) and results expressed as densitometric units (DU).
Results represent means ± S.D. of densitometric units (DU). * Significant difference between
P. gingivalis LPS and E.coli LPS at the same dose (p < 0.01, Kruskal–Wallis test).
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Fig. 2. Enzymatic and quantitative analysis of MMP-9 and of the MMP-9/TIMP-1 ratio in MoDCs
exposed to P. gingivalis LPS
(A) MoDCs were stimulated with 100, 200, 400 and 800 ng/ml of P. gingivalis LPS and
E.coli LPS for 24 hrs. MMP-9 in cell supernatants was analyzed by gelatin zymography. Equal
amounts of protein were loaded and separated by electrophoresis as described in the Materials
and Methods. (B) Gelatin zymogram bands corresponding to 92 kDa (MMP-9) were quantified
by optical densitometry (GelPro Analyzer, Media Cybernetics, Silver Spring, MD). Results
represent means ± S.D. of densitometric units (DU). (C) ELISA analysis of MMP-9 production
in pg/ml by MoDCs in response to 100 ng/ml of either LPS or no LPS (control). Shown are
the means ± S.E. of assay performed in triplicate. * Significant increase in MMP-9 induction
by P. gingivalis LPS compared to E. coli LPS and DC control (p<0.05, Student’s t-test (D)
ELISA analysis of TIMP-1 production in pg/ml by MoDCs in response to 100 ng/ml of either
LPS or no LPS (control). Shown are the means ± S.E. of assay performed in triplicate.
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Fig. 3. Induction of MMP-9, TIMP-1 and IL-10 by P.gingivalis 381, its fimbriae deficient mutants
MoDCs were pulsed with whole cells of wild type Pg 381, its minor fimbriae deficient strain
(MFI), major fimbriae deficient strain (DPG-3) and double-fimbriae deficient mutant strain
(MFB) for 18 h at a MOI of 1:25. Secretion of MMP-9, TIMP-1 and IL-10 in pg/ml were
assessed by ELISA, as described in Materials and Methods. The data are the mean ± S.D. of
triplicate assays. (A) MMP-9 production in response to different fimbriae deficient strains. (B)
Ratio of MMP-9/TIMP-1. (C) Comparison of MMP-9 and IL-10 produced by MoDCs in
response to different fimbriae deficient strains.
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